SCHEDULE 13D/A: Ginkgo Bioworks Founders Update Stake Following 1:40 Reverse Stock Split
Beneficial Ownership Update
Ginkgo Bioworks Holdings, Inc. founders Reshma P. Shetty and Barry Canton have updated their beneficial ownership stake to 9.5% of Class A Common Stock following the company's one-for-forty reverse stock split in August 2024.
Summary
- This Amendment No. 4 updates the Schedule 13D filing by Reshma P. Shetty and Barry Canton regarding their beneficial ownership in Ginkgo Bioworks Holdings, Inc.
- The amendment reflects a one-for-forty (1:40) reverse stock split of the Issuer's Class A, Class B, and Class C Common Stock, which was effected in August 2024.
- It also accounts for an increase in the total number of the Issuer's Class A Common Stock outstanding.
- As a result of these corporate actions, the percentage of Class A Common Stock beneficially owned by the Reporting Persons has decreased.
- As of February 14, 2025, Reshma P. Shetty and Barry Canton each beneficially own 4,716,084 shares, representing 9.5% of the Class A Common Stock.
- This beneficial ownership includes 618,726 shares of Class A Common Stock and 4,097,358 shares of Class B Common Stock, which are convertible into Class A Common Stock on a one-to-one basis.
- The percentage is calculated based on 45,575,423 shares of Class A Common Stock outstanding as of December 31, 2024, plus the 4,097,358 shares issuable upon Class B conversion.
Sentiment
Score: 5
Explanation: Neutral. This is a routine regulatory filing (Schedule 13D Amendment) primarily updating beneficial ownership percentages due to a corporate action (reverse stock split) and changes in outstanding shares. It does not contain information that would typically indicate positive or negative sentiment regarding the company's operational performance or future prospects.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- The beneficial ownership includes shares held by the Reshma Padmini Shetty Living Trust, Bartholomew Canton Living Trust, Ms. Shetty's grantor retained annuity trust, Mr. Canton's grantor retained annuity trust, The Asha S. Canton Irrevocable Trust, and The Adhira S. Canton Irrevocable Trust.
- Reshma P. Shetty and Barry Canton are married and are deemed to share beneficial ownership over shares held by each other and these trusts.
Stakeholder Impact
- Shareholders: Provides updated information on significant insider ownership, which can be relevant for assessing insider alignment and control. The reverse stock split itself impacts share price and number of shares held by all shareholders.
Key Dates
| Date | Description |
|---|---|
| 2021-09-27 | Original Schedule 13D filed by Reporting Persons. |
| 2022-10-01 | Amendment to Original Schedule 13D filed. |
| 2023-01-24 | Amendment to Original Schedule 13D filed. |
| 2024-02-14 | Amendment to Original Schedule 13D filed. |
| 2024-08 | One-for-forty (1:40) reverse stock split of Class A, Class B, and Class C Common Stock effected by the Issuer. |
| 2024-12-31 | Date for Class A Common Stock outstanding count (45,575,423 shares) used for percentage calculation. |
| 2025-02-14 | Date of event requiring filing of this statement and filing date of Amendment No. 4. |
Recommendation
holdKeywords
Ginkgo Bioworks Holdings Inc, Schedule 13D, Beneficial Ownership, Reverse Stock Split, Class A Common Stock, Class B Common Stock, Shareholder Stake, SEC Filing, Biotechnology, Synthetic Biology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.